The role of transglutaminases in neurodegenerative diseases: Overview

Neurochemistry International

Volumn 40, Issue 1, 2002, Pages 1-5

  Cooper, Arthur J L ^a,b   Jeitner, Thomas M ^a,b   Blass, John P ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b BURKE MEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN ENZYME; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

AMINATION; AUTOIMMUNE DISEASE; BRAIN INJURY; CATALYSIS; CELL LOSS; CONFERENCE PAPER; CROSS LINKING; CYTOARCHITECTURE; DEGENERATIVE DISEASE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME BINDING; ENZYME INHIBITION; ENZYME SUBSTRATE; HUMAN; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN STABILITY; SYMPTOM;

HUMANS; NEURODEGENERATIVE DISEASES; TRANSGLUTAMINASES;

EID: 0036135520     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(01)00055-9     Document Type: Conference Paper

References (31)

1. Transglutaminases: Protein cross-linking enzymes in tissues and body fluids
2. Protein cross-linking in assembly and remodelling of extracellular matrices: The role of transglutaminases
3. Metabolic compartments in vivo. Ammonia and glutamic acid metabolism in brain and liver
4. The incorporation of amines into protein
5. Polyglutamine domains are substrates of tissue transglutaminase. Does transglutaminase play a role in expanded CAG/poly-Q neurodegenerative diseases?
6. n-expansion diseases with special reference to the role of tissue transglutaminase and to selective vulnerability
7. Tansglutaminases: Mechanistic features of the active site as determined by kinetic and inhibitor studies
8. Tissue transglutaminase-catalyzed formation of high-molecular-weight aggregates in vitro is favored with long polyglutamine domains: A possible mechanism contributing to CAG-triplet diseases
9. Human genetic diseases due to codon reiteration: Relationship to an evolutionary mechanism
10. Amyloid formation by mutant huntingtin: Threshold, progressivity and recruitment of normal polyglutamine proteins
11. Transglutaminase activity is increased in Alzheimer's disease brain
12. Transglutaminase aggregates huntingtin into nonamyloidogenic polymers, and its enzymatic activity increases in Huntington's disease nuclei
13. Peptides containing glutamine repeats are substrates for transglutaminase-catalyzed cross-linking: Relevance to diseases of the nervous system
14. Transglutaminase action imitates Huntington's disease: Selective polymerization of huntingtin containing polyglutamine
15. Differential expression of multiple transglutaminases in human brain. Increased expression and cross-linking by transglutaminases 1 and 2 in Alzheimer's disease
16. Tissue transglutaminase is increased in Huntington's disease brain
17. Tissue transglutaminase: A possible role in neurodegenerative diseases
18. Polyglutamines, nuclear inclusions and degenerations
19. Amyloid-like inclusions in Huntington's disease
20. Expanded trinucleotide CAG repeats in families with bipolar affective disorders
21. Glutamine repeats and inherited neurodegenerative diseases: Molecular aspects
22. Glutamine repeats and neurodegenerative diseases: Molecular aspects
23. Glutamine repeats as polar zippers: Their possible role in inherited neurodegenerative diseases
24. An enzymatically catalyzed incorporation of amines into proteins
25. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions
26. Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: Implications for Huntington's disease pathology
27. Alzheimer's disease: Insolubility of partially purified helical filaments in sodium dodecyl sulfate and urea
28. Incorporation of glutamine repeats makes protein oligomerize. Implications for neurodegenerative diseases
29. Transglutaminase catalyzed cross-links in intranuclear inclusions in Huntington's disease brain
30. Transglutaminase-induced cross-linking of tau protein in progressive supranuclear palsy
31. Expression of the transglutaminase enzymes in progressive supranuclear palsy